PD-128,907
跳转到导航
跳转到搜索
| File:PD-128,907 Structure.svg | |
| 识别信息 | |
|---|---|
| |
| CAS号 | 123594-64-9 check 300576-59-4（盐酸盐） |
| PubChem CID | |
| ChemSpider | |
| ChEMBL | |
| E编码 | {{#property:P628}} |
| CompTox Dashboard (EPA) |
|
| ECHA InfoCard | {{#property:P2566}}Module:EditAtWikidata第29行Lua错误：attempt to index field 'wikibase' (a nil value) |
| 化学信息 | |
| 化学式 | C14H19NO3 |
| 摩尔质量 | 249.31 g·mol−1 |
| 3D模型（JSmol） | |
| |
PD-128,907（3,4,4a,10b-四氢-4-丙基-2H,5H-[1]苯并吡喃并[4,3-b]-1,4-𫫇嗪-9-酚），分子式C14H19NO3，是一种用于科研的多巴胺受体D2和D3激动剂[1]。其合成已有文献报道。[2]
参考文献[编辑]
- ^ DeWald HA, Heffner TG, Jaen JC, Lustgarten DM, McPhail AT, Meltzer LT, et al. Synthesis and dopamine agonist properties of (+-)-trans-3,4,4a,10b-tetrahydro-4-propyl-2H,5H-[1]benzopyrano [4,3-b]-1,4-oxazin-9-ol and its enantiomers. Journal of Medicinal Chemistry. January 1990, 33 (1): 445–50. PMID 1967318. doi:10.1021/jm00163a068.
- ^ Battiti, Francisco O.; Newman, Amy Hauck; Bonifazi, Alessandro. Exception That Proves the Rule: Investigation of Privileged Stereochemistry in Designing Dopamine D3R Bitopic Agonists. ACS Medicinal Chemistry Letters (American Chemical Society (ACS)). 2020-02-28, 11 (10): 1956–1964. ISSN 1948-5875. doi:10.1021/acsmedchemlett.9b00660.